OBJECTIVE: To study the clinical pathological characteristics and high risk factors for @entity43 ( @entity43 ) and stage @entity43 (EOC). METHODS: A total of 91 @entity1 with @entity43 and 52 @entity1 with stage IEOC who were diagnosed and treated in the Department of Gynecology, Peking University @entity1 's Hospital from November 2002 to May 2010 were recruited in this study. The @entity1 ' clinical characteristics were reviewed respectively and compared between the two groups. RESULTS: The @entity1 in @entity43 group were significantly younger than those in EOC group (41.16    14.95 vs. 50.90    14.37,P<0.01). Compared with @entity1 with @entity43 , @entity1 with EOC were more likely to be post-menopausal(42.3% vs. 23.1%,P=0.016) and more with family history of @entity5 (26.9% vs. 13.2%,P=0.04).There were no significant differences in the size of @entity5 and the serum level of @entity5 markers. But the size of solid portion of the @entity5 of EOC was significantly larger than that of @entity43 (P<0.01). The extent of the increase of @entity23831 among the @entity1 with EOC was higher than that among the @entity1 with @entity43 (256.99 vs. 116.59, P=0.028). There was a statistically significant difference between the two groups in @entity5 ' histopathological type(P<0.01). The serous and mucous @entity5 were more common in EOC group (90.1%, 82/91). In contrary, endometrioid, clear cells and mixed @entity5 were more common in EOC group than serous and mucous @entity5 (44.2%, 23/52). CONCLUSION: Although the clinical presentation of @entity1 with stage I EOC was similar to that of those with @entity43 , there were significant differences in the @entity1 ' age, post-menopausal or not, family history of @entity5 , size of solid portion of @entity5 , extent of the increase of the @entity5 biomarker, especially of @entity23831 and @entity5 histopathological type. These clinicopathological characteristics might be helpful for us to make different diagnosis.

[Clinical characteristics of @entity43 and stage XXXX : an analysis of 143 cases].

@entity43 :: ('MESH:D010051', 'Disease') :: ['I epithelial ovarian cancer', 'borderline ovarian tumor', 'BOT'] @entity1 :: ('9606', 'Species') :: ['women', 'patients', 'People'] @entity5 :: ('MESH:D009369', 'Disease') :: ['epithelial cancers', 'tumor', 'malignant tumors', 'cancers', 'tumors'] @entity23831 :: ('1356', 'Gene') :: ['CP2']
@entity43 :: (MESH:D010051,Disease) :: ['I epithelial ovarian cancer']
